Correction: MRI correlates of disability in African-Americans with multiple sclerosis (PLoS ONE)

Jonathan Howard; Marco Battaglini; James Scott Babb; Donatello Arienzo; Brigitte Holst; Mirza Omari; Nicola De Stefano; Joseph Herbert; Matilde Inglese

doi:10.1371/annotation/25df480c-60b5-43a3-b03c-4e97d6ee399c

Correction: MRI correlates of disability in African-Americans with multiple sclerosis (PLoS ONE)

Jonathan Howard, Marco Battaglini, James Scott Babb, Donatello Arienzo, Brigitte Holst, Mirza Omari, Nicola De Stefano, Joseph Herbert, Matilde Inglese

Research output: Contribution to journal › Comment/debate

Original language	English
Journal	PLoS ONE
Volume	8
Issue number	6
DOIs	https://doi.org/10.1371/annotation/25df480c-60b5-43a3-b03c-4e97d6ee399c
State	Published - 7 Jun 2013

Access to Document

10.1371/annotation/25df480c-60b5-43a3-b03c-4e97d6ee399c

Cite this

@article{d4c0859e6b214c17a0c29e5acdd547f3,

title = "Correction: MRI correlates of disability in African-Americans with multiple sclerosis (PLoS ONE)",

author = "Jonathan Howard and Marco Battaglini and Babb, {James Scott} and Donatello Arienzo and Brigitte Holst and Mirza Omari and {De Stefano}, Nicola and Joseph Herbert and Matilde Inglese",

note = "Funding Information: Author Mirza Omari was incorrectly mentioned in the Funding Statement. The following is the correct Funding Statement: The study was funded in part by National institute of health (NIH) [grant R01 NS051623 to Matilde Inglese]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Mirza Omari was incorrectly mentioned in the Competing Interest Statement. The following is the correct Competing Interest Statement: Nicola De Stefano serves on the scientific advisory boards for Merck Serono and Novartis; he has received funding for travel from Merck Serono, Novartis and Teva Pharmaceutical Industries ltd.; he has received speaker honoraria from Novartis, Teva Pharmaceutical lndustries ltd., Biogen-Domp{\'e}, Schering-Bayer, Sanofi-Aventis, and Merck Serono. Joseph Herbert has received grants from Biogen, Teva, Merk Serono and Bayer. Matilde Inglese is funded by NIH grant R01 NS051623. Matilde Inglese serves on the scientific advisory board of Celgene and she has served as consultant for Vaccinex and Biogen. This does not alter the authors{\textquoteright} adherence to all the PLoS ONE policies on sharing data and materials.",

year = "2013",

month = jun,

day = "7",

doi = "10.1371/annotation/25df480c-60b5-43a3-b03c-4e97d6ee399c",

language = "English",

volume = "8",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "6",

}

TY - JOUR

T1 - Correction

T2 - MRI correlates of disability in African-Americans with multiple sclerosis (PLoS ONE)

AU - Howard, Jonathan

AU - Battaglini, Marco

AU - Babb, James Scott

AU - Arienzo, Donatello

AU - Holst, Brigitte

AU - Omari, Mirza

AU - De Stefano, Nicola

AU - Herbert, Joseph

AU - Inglese, Matilde

N1 - Funding Information: Author Mirza Omari was incorrectly mentioned in the Funding Statement. The following is the correct Funding Statement: The study was funded in part by National institute of health (NIH) [grant R01 NS051623 to Matilde Inglese]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Mirza Omari was incorrectly mentioned in the Competing Interest Statement. The following is the correct Competing Interest Statement: Nicola De Stefano serves on the scientific advisory boards for Merck Serono and Novartis; he has received funding for travel from Merck Serono, Novartis and Teva Pharmaceutical Industries ltd.; he has received speaker honoraria from Novartis, Teva Pharmaceutical lndustries ltd., Biogen-Dompé, Schering-Bayer, Sanofi-Aventis, and Merck Serono. Joseph Herbert has received grants from Biogen, Teva, Merk Serono and Bayer. Matilde Inglese is funded by NIH grant R01 NS051623. Matilde Inglese serves on the scientific advisory board of Celgene and she has served as consultant for Vaccinex and Biogen. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.

PY - 2013/6/7

Y1 - 2013/6/7

UR - http://www.scopus.com/inward/record.url?scp=84896094553&partnerID=8YFLogxK

U2 - 10.1371/annotation/25df480c-60b5-43a3-b03c-4e97d6ee399c

DO - 10.1371/annotation/25df480c-60b5-43a3-b03c-4e97d6ee399c

M3 - Comment/debate

AN - SCOPUS:84896094553

SN - 1932-6203

VL - 8

JO - PLoS ONE

JF - PLoS ONE

IS - 6

ER -